In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AiCuris Anti-infective Cures GmbH

www.aicuris.com

Latest From AiCuris Anti-infective Cures GmbH

Royalty Pharma Nears Biopharma Record Take With $2.18bn IPO

Company specializing in trading upfront cash for downstream earnings makes its public debut with largest IPO of 2020, and the second largest ever in biopharma.

Financing Business Strategies

Deal Watch: Genentech Inks New Collaborations With Skyhawk, Convelo

Skyhawk continues its recent spate of deal-making, using its SkyStar platform in a deal with Genentech, which also is looking into neurology with Convelo. AbbVie buys STING specialist Mavupharma, while Recordati pays Novartis $390m for Cushing’s products.

Deals Business Strategies

Bursting Bacteria And Busting Resistance: AiCuris And Lysando’s New Partnership

German anti-infectives firm AiCuris partners to develop new class of Artilysin antimicrobials that rapidly burst bacterial cells and could have an improved resistance profile.

Deals Infectious Diseases

Bridging The Gap: Cyclenium Pharma

Emerging Company Profile: Cyclenium Pharma spoke with Scrip about macrocyclic drug discovery, which covers the molecular space between traditional small molecules and large bio-molecules, to capture the pharmacological properties of larger peptides/proteins in metabolically stable small molecules and proven in a broad range of target classes.

Infectious Diseases StartUps and SMEs
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
  • Pharmaceuticals
  • Therapeutic Areas
  • Infectious & Viral Diseases
  • Alias(es)
  • AiCuris GMBH & Co. KG
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • AiCuris Anti-infective Cures GmbH
  • Senior Management
  • Holger Zimmermann, PhD, CEO
    Holger Schmoll, CFO
    Alexander Birkmann, Head, Rsch.
    Manickam Rangaraju, MD, Head, Dev.
  • Contact Info
  • AiCuris Anti-infective Cures GmbH
    Phone: (49) (0)202 317 63
    Friedrich-Ebert-Str. 475, Bldg. 302
    Wuppertal, D-42117
    Germany
UsernamePublicRestriction

Register